This inventor holds 1 USPTO granted patent. Top assignee: Pharmagene Laboratories Limited. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: Richard A Borman: Innovator in IBS Treatment
Introduction
Richard A Borman is a notable inventor based in Hertfordshire, GB. He has made significant contributions to the field of medical treatment, particularly in addressing issues related to Irritable Bowel Syndrome (IBS). His innovative approach has led to the development of a unique assay method that targets specific receptors in the human colon.
Latest Patents
Borman holds a patent for an "Assay method for detecting 5-HT2B antagonists." This invention is centered around the discovery that receptors for the neurotransmitter 5-HT are present in the human colon. The activation of these receptors is linked to abnormal motility and pain associated with IBS. The patent outlines a method of treatment that involves administering an effective amount of a 5HT2B receptor antagonist to patients suffering from IBS. These antagonists can be delivered through various formulations, including depot formulations and suppositories.
Career Highlights
Richard A Borman is associated with Pharmagene Laboratories Limited, where he has been instrumental in advancing research and development in gastrointestinal treatments. His work has focused on creating effective solutions for patients dealing with IBS, showcasing his commitment to improving healthcare outcomes.
Collaborations
Borman has collaborated with notable colleagues, including Nicholas Tilford and Gordon Smith Baxter. Their combined expertise has contributed to the successful development of innovative treatments in the field.
Conclusion
Richard A Borman's contributions to the medical field, particularly through his patent on IBS treatment, highlight his role as an innovator. His work continues to pave the way for advancements in understanding and treating gastrointestinal disorders.